UNSPSC 51281636: Astromicin sulfate

This classification denotes an aminoglycoside antibiotic with the molecular formula C17H35N5O6.2H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier POY3S0T3BD, chemically known as 4-amino-1-(2-amino-n-methylacetamido)-1,4-dideoxy-3-o-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-l-lyxo-heptopyranosyl)-6-o-methyl-l-chiro-inositol sulfate (1:2) (salt) but more generally known as astromicin sulfate, which bears US NIH Compound Identifier 51565.

UNSPSC 51281636 Astromicin sulfate is a Commodity code with minimal recent procurement activity directly under this specific pharmaceutical product, though state and local buyers are actively procuring pharmaceutical supplies and medications across related categories. The opportunities in the source reflect broader patterns in state and local procurement for medical supplies, pharmaceuticals, and pharmacy benefit programs rather than astromicin specifically. State and local governments purchasing under this code and related pharmaceutical commodities include county health departments, municipal fire-rescue divisions, state health agencies, and cooperative purchasing alliances serving multi-state government membership. The kinds of work involve procuring finished pharmaceutical products, medications, and emergency medical supplies for public health, emergency response, and employee health benefit programs, typically through sealed competitive bidding or request-for-proposal processes with strict compliance requirements around expiration dating, manufacturing standards, and supply-chain security.

Recent procurement activity appears concentrated in Florida and Minnesota, with exploratory activity in Texas. Seminole County, Florida (IFB 60459723LAS, due July 26, 2026) solicited naloxone and drug deactivation systems for quarterly delivery to community health facilities. The City of Tampa (Bid 26P00145, due March 13, 2026) sought medical and first aid supplies—169 line items including respiratory equipment, cardiac monitoring electrodes, and oxygen delivery systems—for the Fire Department Rescue Division, with an estimated contract amount of $700,000 and a sheltered market designation for certified Small Local Business Enterprises offering a 5% bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic multi-source pharmaceuticals and over-the-counter products (S1070000015802, due March 26, 2026) distributed across state and local government facilities in Minnesota and Oregon, requiring vendor compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act. The Texas Health and Human Services Commission issued a preliminary Request for Information (RFI HHS0017013, due April 3, 2026) exploring direct-to-manufacturer prescription fulfillment strategies outside traditional pharmacy benefit manager channels.